Will the Coronary Artery Block Again After a Cardiac Stent

A Angioplasty is a safe and effective way to unblock coronary arteries. During this procedure, a catheter is inserted into the groin or arm of the patient and guided forward through the aorta and into the coronary arteries of the center. At that place, blocked arteries can be opened with a airship positioned at the tip of the catheter. Initially, angioplasty was performed simply with airship catheters, merely technical advances take been made and improved patient outcome has been achieved with the placement of small metal jump-similar devices chosen "stents" (Figure 1) at the site of the blockage. The implanted stent serves as a scaffold that keeps the artery open up.

• Download figure
• Download PowerPoint

Effigy 1. Size of an expanded coronary stent in relation to a dime. The stent is 18 mm in length and 3.5 mm in diameter.

Angioplasty and stenting techniques are widely used around the world and provide an alternative option to medical therapy and bypass surgery for improving claret catamenia to the eye muscle. There are, notwithstanding, limitations associated with angioplasty and stenting, ane of which is chosen "restenosis."

What does restenosis mean?

Restenosis occurs when the treated vessel becomes blocked once more. It usually occurs within 6 months after the initial procedure.^ane Compared with airship angioplasty alone, where the chance of restenosis is 40%, stents reduce the chance of restenosis to 25%.^2,iii Therefore, the majority of patients having angioplasty today are treated with stents. Restenosis can occur after the apply of stents, and physicians refer to this as "in-stent restenosis."

Why does in-stent restenosis happen?

When a stent is placed in a blood vessel, new tissue grows inside the stent, covering the struts of the stent. Initially, this new tissue consists of healthy cells from the lining of the arterial wall (endothelium). This is a favorable effect because development of normal lining over the stent allows claret to menses smoothly over the stented area without clotting. Later, scar tissue may form underneath the new healthy lining. In about 25% of patients, the growth of scar tissue underneath the lining of the artery may exist so thick that information technology tin can obstruct the blood period and produce an important blockage. In-stent restenosis is typically seen 3 to six months subsequently the procedure; after 12 months have passed uneventfully, information technology is rare.

Who is at high take chances for in-stent restenosis?

Patients with diabetes are at increased risk for in-stent restenosis. Further important take a chance factors relate to the properties of the blocked artery and the pattern of scar tissue growth inside the avenue; the more all-encompassing the scar tissue growth, the worse the prognosis is.⁴

What are the symptoms of in-stent restenosis?

In-stent restenosis may produce symptoms that are very similar to the symptoms that initially brought the patient to the interventional cardiologist, such as chest pain triggered by exertion. Diabetic patients, however, may have fewer symptoms, atypical and unusual symptoms, or fifty-fifty no symptoms at all. Fortunately, a center attack does not usually occur even if in-stent restenosis develops.

How can we observe in-stent restenosis?

Subsequently stenting of coronary arteries, patients should follow-up with their cardiologist at regular intervals.

When symptoms occur afterward the procedure, the cardiologist may recommend diagnostic tests (for instance, an do stress test) to evaluate whether the patient is likely to have developed in-stent restenosis or another coronary avenue is blocked. If in-stent restenosis is a possibility, the cardiologist may refer the patient for a repeat cardiac catheterization (Effigy 2).

• Download figure
• Download PowerPoint

Figure 2. Development and treatment of in-stent restenosis. A, Coronary artery blocked by an atherosclerotic plaque. B, Unblocked coronary artery with an expanded stent. C, In-stent restenosis (scar tissue built up inside the stent). D, Balloon catheter in identify to open up coronary artery after occurrence of in-stent restenosis. East, Localized radiation therapy (brachytherapy) delivered to the location of in-stent restenosis by a special catheter to avert recurrence of in-stent restenosis. F, Opened coronary avenue subsequently successful brachytherapy of in-stent restenosis. Drug-eluting stents preclude scar-tissue growth and may altogether obviate processes C through F.

Tin can in-stent restenosis be prevented?

Prevention of in-stent restenosis starts at the point of stent implantation. The physician's knowledge of advisable stent placement is crucial. Some specialized centers may perform imaging with a special catheter from the inside of the vessel (ultrasound). This technique allows more accurate placement and expansion of stents⁵ and may help in the prevention of restenosis. Drugs and vitamins administered either orally or intravenously have been tested for prevention of restenosis and in-stent restenosis, but have non been consistently shown to be helpful.

New Techniques to Prevent Restenosis: Drug-Eluting Stents

During the last year, a quantum for the prevention of in-stent restenosis occurred in the form of a new generation of "drug-eluting" stents. These stents carry a special drug on their surface that prevents scar tissue growth in the artery where the stent is placed, and they therefore markedly reduce the occurence of in-stent restenosis. Recent data demonstrated that patients treated with drug-eluting stents had decreased incidence of in-stent restenosis compared with those who received blank metal stents.⁶ Drug-eluting stents are not yet canonical by the FDA, and the results of further studies are awaited.

How do nosotros care for restenosis?

Echo angioplasty or bypass surgery can be used to care for in-stent restenosis. In addition, local intravascular radiation (brachytherapy) can be used afterwards treating in-stent restenosis with angioplasty to preclude reoccurrence.⁷ Brachytherapy uses a radioactive source that is delivered by a coronary artery catheter within the narrowed artery for a short period of fourth dimension (well-nigh x minutes). The source is removed and does non stay in the body. Because the short period of radiation inhibits long-term tissue growth in the treated vessel, information technology successfully prevents in-stent restenosis. Both β- and γ-irradiation are helpful in this setting.⁷ Only a few centers, however, take the special expertise needed to perform brachytherapy.

What can patients practise to protect themselves?

After the process, patients should lead a heart-healthy lifestyle that includes a diet depression in animal fat, regular exercise, blood force per unit area control, cessation of smoking, and minimal alcohol consumption. Regularly following-upwardly with a cardiologist and taking medications every bit prescribed are also important preventive measures.

For additional discussion on in-stent restenosis, see www.heartcenteronline.com and www.tctmd.com.

Footnotes

Correspondence to George Dangas, Doctor, PhD, Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Found, 55 Eastward 59th Street, 6th Floor, New York, NY, 10022. E-mail [email protected]

References

• 1 Serruys Pw, Luijten HE, Beatt KJ, et al. Incidence of restenosis afterwards successful coronary angioplasty: a time- related miracle: a quantitative angiographic study in 342 consecutive patients at 1, two, 3, and 4 months. Circulation . 1988; 77: 361–371.CrossrefMedlineGoogle Scholar
• 2 Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of airship-expandable-stent implantation with balloon angioplasty in patients with coronary avenue disease. Benestent Study Grouping. North Engl J Med . 1994; 331: 489–495.CrossrefMedlineGoogle Scholar
• 3 Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Report Investigators. Due north Engl J Med . 1994; 331: 496–501.CrossrefMedlineGoogle Scholar
• 4 Mehran R, Dangas Chiliad, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Apportionment . 1999; 100: 1872–1878.CrossrefMedlineGoogle Scholar
• 5 Fitzgerald PJ, Oshima A, Hayase One thousand, et al. Final results of the Tin can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation . 2000; 102: 523–530.CrossrefMedlineGoogle Scholar
• 6 Sousa JE, Costa MA, Abizaid Air-conditioning, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-upward. Circulation . 2001; 104: 2007–2011.CrossrefMedlineGoogle Scholar
• vii Leon MB, Teirstein PS, Moses JW, et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis later on stenting. N Engl J Med . 2001; 344: 250–256.CrossrefMedlineGoogle Scholar

degruchymancien.blogspot.com

Source: https://www.ahajournals.org/doi/10.1161/01.cir.0000019122.00032.df

Share this post